This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

About the NKI

The Netherlands Cancer Institute was established on October 10, 1913. The founders, Rotgans, professor of Surgery, De Bussy, publisher, and De Vries, professor of Pathology, wanted to create a cancer institute 'where patients suffering from malignant growths could be treated adequately and where cancer and related diseases could be studied'. They bought a house on one of the canals in Amsterdam and named it the 'Antoni van Leeuwenhoek Huis', after the famous Dutch microscopist. The clinic had room for 17 patients, while the laboratory could accommodate 8 to 10 scientists.

Nowadays, The Netherlands Cancer Institute accommodates approximately 650 scientists and scientific support personnel. The Antoni van Leeuwenhoek Hospital has 185 medical specialists, 180 beds, an out-patients clinic with around 106,000 visits, 12 operating theaters and 11 irradiotion units for radiotherapy. It is the only dedicated cancer center in The Netherlands and maintains an important role as a national and international center of scientific and clinical expertise, development and training.


  • 24May 2019

    Three NKI scientists receive Vidi-grant

    Three experienced researchers from the Netherlands Cancer Institute have each been awarded a 800.000 euro Vidi grant from NWO. The grant enables Olga Husson, Leila Akkari and Martin Fast to develop their own innovative line of research in the coming five years. Fascinating research on immunotherapy for brain cancer, software for improved radiotherapy, and long term outcomes after cancer (treatment) in young adult patients.

    Read More
  • 22May 2019

    PhD student utilizes evolution - Thesis Bart van Beusekom

    Did you know that human DNA copy machines are almost identical to those of chimpanzees? Researcher Bart van Beusekom from the Netherlands Cancer Institute used such similarities to develop software that allows scientists to better solve new protein structures. On Monday May 27th he will defend his PhD thesis at Utrecht University.

    Read More
  • 14May 2019

    New study on immunotherapy in triple negative breast cancer

    It sounds complicated: giving cancer patients chemotherapy or radiotherapy, not with the aim of killing cancer cells, but to put the immune system to work so that it will respond better to immunotherapy. Nonetheless, preclinical studies have shown that this is a promising new way to increase the chance of success of immunotherapy. It can strengthen the good immune cells and weaken immune cells that aid cancer.

    Read More
  • 10May 2019

    FacesofNKI: Leila Akkari

    FacesofNKI: meet Leila Akkari Hundreds of scientists at the Netherlands Cancer Institute dedicate their lives to finding ways to outsmart cancer. Who are they? Meet Leila Akkari, whose scientific curiosity stems from different corners of the globe and drives her to hijack the hijackers. #facesofNKI

    Read More

Board of Directors

Overview boards and commissions


Internal procedures

The NKI has adopted several regulations and procedures which help us organize our research along national and international standards. The most important regulations and procedures can be found here.

Read more


Technology Transfer Office

The NKI has a mission to beat cancer and performs world-beating research to increase our understanding of this disease. The knowledge that is gained in this way sometimes opens avenues for development of e.g. novel treatments or new diagnostic tests. To achieve its mission, NKI actively collaborates with private companies that have the knowledge and the means to develop products based on research results obtained at our institution.

Go to the site of the Technology Transfer Office

Scientific Annual Reports (SAR)



Group Leaders51
PhD Students187


  • Silhoutten



  • Silhoutten



  • Horloge



  • Silhoutten



  • Bed



Key Figures Research

Publications in 2016 805
Total impact of publications in 2014 3935
Avarage impact of publications 2014 6.8

Key Figures Research

Number of divisions 15
Number of Reseach groups 51
Share this page